PIPA568166

APOBEC3H Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA568166-Each-of-1 In Stock ₹ 46,502.50

PIPA568166 - Each of 1

₹ 46,502.50

In Stock

Quantity

1

Base Price: ₹ 46,502.50

GST (18%): ₹ 8,370.45

Total Price: ₹ 54,872.95

Antigen

APOBEC3H

Classification

Polyclonal

Conjugate

Unconjugated

Gene

APOBEC3H

Gene Alias

A3H; APOBEC3H; APOBEC-related protein 10; apolipoprotein B mRNA editing enzyme catalytic polypeptide like 3H; apolipoprotein B mRNA editing enzyme catalytic subunit 3H; apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H; Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3H; ARP10; ARP-10; DNA dC->dU-editing enzyme APOBEC-3H

Host Species

Rabbit

Purification Method

affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

164668

Content And Storage

-20°C

Form

Liquid

Applications

Western Blot

Concentration

1 mg/mL

Formulation

PBS with 50% glycerol and 0.02% sodium azide; pH 7.4

Gene Accession No.

Q6NTF7

Gene Symbols

APOBEC3H

Immunogen

Synthesized peptide derived from human APOBEC3H.

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA567638

--

Img

Thermo Scientific

PIPA599584

--

Img

Thermo Scientific

PIPA540735

--

Img

Thermo Scientific

PIPA599847

--

Img

Thermo Scientific

PIPA5101430

--

Img

Thermo Scientific

PIPA575388

--

Img

Thermo Scientific

PIPA577861

--

Img

Thermo Scientific

PIPA568083

--

Description

  • DNA deaminase (cytidine deaminase) which acts as an inhibitor of retrovirus replication and retrotransposon mobility via deaminase-dependent and -independent mechanisms
  • The A3H-var/haplotype 2 exhibits antiviral activity against vif-deficient HIV-1
  • After the penetration of retroviral nucleocapsids into target cells of infection and the initiation of reverse transcription, it can induce the conversion of cytosine to uracil in the minus-sense single-strand viral DNA, leading to G-to-A hypermutations in the subsequent plus-strand viral DNA
  • The resultant detrimental levels of mutations in the proviral genome, along with a deamination-independent mechanism that works prior to the proviral integration, together exert efficient antiretroviral effects in infected target cells
  • Selectively targets single-stranded DNA and does not deaminate double-stranded DNA or single- or double-stranded RNA
  • Exhibits antiviral activity also against T-cell leukemia virus type 1 (HTLV-1) and may inhibit the mobility of LTR and non-LTR retrotransposons.